Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine.
Jorda, Radek; Dusek, Jan; Reznícková, Eva; Pauk, Karel; Magar, Pratibha P; Imramovský, Ales; Krystof, Vladimír.
Eur J Med Chem
; 135: 142-158, 2017 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-28441582
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors.
Substituted quinolines as noncovalent proteasome inhibitors.
Tyropeptins, proteasome inhibitors produced by Kitasatospora sp. MK993-dF2.
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells.
Immunoproteasome inhibition and bioactivity of thiasyrbactins.
Proteasome inhibitors for multiple myeloma.
Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening.
Potential peptidic proteasome inhibitors by incorporation of an electrophilic trap based on amino acid derived α-substituted sulfonyl fluorides.
Indolo-phakellins as ß5-specific noncovalent proteasome inhibitors.